Osteoporotic risk in Crohn's disease.

2005

-Correlation between deficiency of 25 (OH) vitamin D and liver damage in adult talassemic subjects

2004

Mevolonate Pathway:role of bisphosphonates and statins

2006

Cardiovascular diseases, i.e. high blood pressure, coronary heart disease, and stroke, and osteoporosis are public health problems, with several epidemiological links, and they might be related to each other in terms of pathogenesis and therapeutic agents. Bisphosphonates inhibit bone resorption and are used in the treatment of osteoporosis, whereas statins inhibit cholesterol biosynthesis and are used for the treatment of atherosclerosis and lipid metabolic disorders. Some late clinical studies suggested bisphosphonates may have beneficial effect in vivo on atherosclerotic progression, lipid profiles, and cardiovascular morbidity and mortality, whereas statins might increase bone density, …

La Familiarità per l'osteoporosi come fattore predittivo per il metabolismo estrogenico

2004

Correlation between deficienty of 25 (oh) vitamin D and liver damage in adult talassemic subjects

2004

Differences in early dynamics of serum bone markers in women with postmenopausal osteoporosiseated by alendronate or risedronate

2004

Correlation between deficiency of 25 (OH) vitamin D, bone mineral density and markers of bone turnover in sicialian postmenopausal womens

2004

Differences in early dynamics of serum bone markers in women with postmenopausal osteoporosis treated by alendronate or risedronate

2004

Some cardiac effects during short-acting beta2-agonist theraphy in COPD subiects

2006

Bone turnover markers in postmenopausal womens treated with alendronate or risedronate: differences in early dynamics

2004

Il trattamento dell'iperparatiroidismo primitivo asintomatico:una controversia ancora aperta

2006